Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models. Devarajan R, Izzi V, Peltoketo H, Rask G, et al. J Clin Invest 2023 Jul 27:e159181. doi: 10.1172/JCI159181.

Read + Share

Amedeo Smart

Independent Medical Education

Devarajan R, Izzi V, Peltoketo H, Rask G, et al. Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models. J Clin Invest 2023 Jul 27:e159181. doi: 10.1172/JCI159181.
PMID: 37498672